DIANE WILKINS: Open Payments
NPI 1407816267 · TOPEKA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,178 in 46 payments from 15 companies in 2025. Trend: 2023 $1,321 · 2024 $1,209 · 2025 $1,178
Food & beverage: $1,178
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. | 6 | $227 |
| Alnylam Pharmaceuticals Inc. | 4 | $199 |
| Novo Nordisk Inc | 9 | $180 |
| Edwards Lifesciences Corporation | 1 | $126 |
| E.R. Squibb & Sons, L.L.C. | 4 | $72 |
| Merck Sharp & Dohme LLC | 4 | $70 |
| PFIZER INC. | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $50 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
Products named: Attruby, Wegovy, AMVUTTRA, SAPIEN 3 Ultra RESILIA, VERQUVO, ELIQUIS, JARDIANCE, ONPATTRO.
Industry payments across KS — which companies pay providers there.
